Good Publication Practice
for pharmaceutical companies

The GPP guidelines encourage responsible and ethical publication of the results of clinical trials sponsored by pharmaceutical companies

We aim to stimulate discussion between journals, investigators and trial sponsors and to provide guidance to those who seek it

We hope that pharmaceutical companies and others involved in developing company-sponsored publications
will endorse the guidelines

SUPPORT FOR GPP
House of Commons Health Committee 
calls on companies to follow GPP
(click here)  

Good Publication Practice (GPP) for pharmaceutical companies

Background notes on GPP

Editorial

Companies endorsing and supporting GPP

GPP Working Group

Contact us

Links to other organizations  

 

Thank you for your interest in GPP